Inactive Instrument

News Ophthotech Corp Nasdaq

Equities

US6837451037

Summary

Unlock all the news: Be the first to know and act before the market!

Iveric Bio - Astellas Receives Permanent J-code for IZERVAY for Geographic Atrophy	Mar. 27	AQ
Loan for Acquisition of U.S. Ophthalmic R&D Company IVERIC bio, Inc. by Astellas Pharma Inc	23-09-29	AQ
Two-time Emmy Award-Winning Actor, Eric Stonestreet, Partners with Iveric Bio to Raise Awareness of Geographic Atrophy	23-09-21	AQ
IVERIC bio, Inc. Announces Positive 24-Month Topline Results from Phase 3 Study of IZERVAY? (avacincaptad pegol intravitreal solution) for Geographic Atrophy	23-09-18	CI
Astellas Pharma Inc. - European Medicines Agency Accepts Iveric Bio's Marketing Authorization Application for Avacincaptad Pegol for Geographic Atrophy	23-08-18	AQ
European Medicines Agency Accepts Iveric Bio's Marketing Authorization Application for Avacincaptad Pegol for Geographic Atrophy	23-08-17	CI
Iveric Bio Receives U.S. FDA Approval for IZERVAY? (avacincaptad pegol intravitreal solution), a New Treatment for Geographic Atrophy	23-08-04	CI
IVERIC bio's Acquisition by Astellas Pharma Completed	23-07-12	MT
Astellas Pharma Completes $5.9 Billion Acquisition of Iveric bio	23-07-11	MT
Astellas Completes Acquisition of Iveric Bio	23-07-11	PR
IVERIC bio, Inc.(NasdaqGS:ISEE) dropped from NASDAQ Composite Index	23-07-11	CI
IVERIC bio, Inc.(NasdaqGS:ISEE) dropped from S&P Biotechnology Select Industry Index	23-07-11	CI
IVERIC bio, Inc.(NasdaqGS:ISEE) dropped from S&P Global BMI Index	23-07-11	CI
IVERIC bio, Inc.(NasdaqGS:ISEE) dropped from S&P TMI Index	23-07-11	CI
Astellas US Holding, Inc. completed the acquisition of IVERIC bio, Inc. from BlackRock, Inc., Deep Track Capital, LP, The Vanguard Group, Inc. and others.	23-07-10	CI
IVERIC bio, Inc.(NasdaqGS:ISEE) dropped from NASDAQ Biotechnology Index	23-07-10	CI
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	23-07-05	BU
IVERIC BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. - ISEE	23-06-14	BU
Insider Sell: Iveric Bio	23-06-06	MT
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)	23-06-05	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Ophthotech Corp Nasdaq

Equities

US6837451037

Summary

Filters